|
![Center for Devices and Radiological Health](https://content.govdelivery.com/attachments/fancy_images/USFDA/2022/06/6011439/4171995/cdrh-standard-banner_crop.png) ![Bookmark and Share](https://content.govdelivery.com/assets/share_this-795413ad3d604760a450815a10e46c8ea06b7315facb759ffdacbc7b7830f87b.gif)
By the end of 2024, the U.S. Food and Drug Administration (FDA) intends to withdraw Laser Products - Conformance with IEC 60825-1 and IEC 60601-2-22 (Laser Notice No. 50). This change is because newer International Electrotechnical Commission (IEC) standards have been issued.
This announcement ensures stakeholders have time to transition to Laser Products - Conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 (Laser Notice No. 56).
Laser Notice No. 56 describes:
- FDA’s current approach to manufacturers’ compliance with the FDA’s performance standards for laser products, and
- how laser manufacturers can use portions of IEC 60825-1 Edition 3.0 and 60601-3-22 Edition 3.1 with the FDA’s performance standard when certifying laser products.
Questions?
If you have questions about Laser Notice No. 56, contact the Division of Industry and Consumer Education.
|
|
|
|